Related Experiment Video
Updated: Dec 13, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis
1Department of Gynaecology, Rizhao People's Hospital, Rizhao, China. hekesongkeng1598@163.com.
Objective:
Long non-coding RNAs (lncRNAs) have been found to exert specific functions in the progression of ovarian cancer (OC), except for lncRNA-OIP5-AS1. In this study, we aim at exploring the molecular mechanisms of OIP5-AS1 in OC.
Patients And Methods:
The expression levels of OIP5-AS1, miR-324-3p, and NFIB in OC tissues and OC cell lines were explored by qRT-PCR assay. The OC cell vitality was examined by CCK-8 and transwell assay. The protein expression level of NFIB was measured by Western blot analysis. The correlation between OIP5-AS1, miR-324-3p, and NFIB was appraised by Dual-Luciferase reporter assay.
Results:
OIP5-AS1 and NFIB were validated to be upregulated in both OC tissues and OC cell lines. Inversely, miR-324-3p downregulation was found in OC tissues and OC cell lines. Functionally, OIP5-AS1 knockdown and miR-324-3p overexpression restrained SKOV3 cell viability, invasion, and migration. Our results verified that OIP5-AS1 inhibited the expression of miR-324-3p in OC. Moreover, miR-324-3p directly targets NFIB. Besides that, NFIB silencing restrained the progression of SKOV3 cells.
Conclusions:
The present study clarified that OIP5-AS1 accelerated OC progression by sponging miR-324-3p and upregulating NFIB. OIP5-AS1 can be a possible therapeutic target for the treatment of OC.
Insights
Long non-coding RNA OIP5-AS1 accelerates ovarian cancer (OC) progression by sponging miR-324-3p and upregulating NFIB. This suggests OIP5-AS1 is a potential therapeutic target for OC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) play roles in ovarian cancer (OC) progression.
- The specific functions of lncRNA-OIP5-AS1 in OC remain largely unexplored.
Purpose of the Study:
- To investigate the molecular mechanisms of OIP5-AS1 in ovarian cancer.
- To elucidate the role of OIP5-AS1 in OC progression and its potential as a therapeutic target.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to assess expression levels of OIP5-AS1, miR-324-3p, and NFIB.
- Cell viability, invasion, and migration assays (CCK-8, Transwell) to evaluate OC cell behavior.
- Western blot analysis for NFIB protein levels and Dual-Luciferase reporter assay for molecular interactions.
Main Results:
- OIP5-AS1 and NFIB were upregulated, while miR-324-3p was downregulated in OC tissues and cell lines.
- OIP5-AS1 knockdown and miR-324-3p overexpression inhibited OC cell viability, invasion, and migration.
- OIP5-AS1 was found to inhibit miR-324-3p, which directly targets NFIB, and NFIB silencing suppressed OC cell progression.
Conclusions:
- OIP5-AS1 promotes OC progression by sponging miR-324-3p and upregulating NFIB.
- OIP5-AS1 represents a potential therapeutic target for ovarian cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
